SAL-0195

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameSAL-0195
Drug Alias NameSAL0195SAL-0195
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsDyslipidemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A